Legend Biotech (LEGN) Price/Sales Ratio
Market Cap: $3.16B
Avg Volume: 1.29M
Industry: Biotechnology
Sector: Healthcare
What is Legend Biotech's Price/Sales Ratio?
- Legend Biotech's trailing twelve month (TTM) Price/Sales ratio is 5.04.
- Legend Biotech's annual Price/Sales ratio as of today is 4.74.
- Legend Biotech's quarterly Price/Sales ratio is 15.95.
What is the Price/Sales Ratio?
The Price/Sales ratio (P/S ratio) is a valuation metric that compares a company's stock price to its revenues. A lower P/S ratio may indicate that a stock is undervalued.
How is the Price/Sales Ratio calculated?
The Price/Sales ratio is calculated by dividing the company's market capitalization by its total sales or revenue. The formula is:
P/S Ratio = Market Capitalization / Total Sales (Revenue)
Related Metrics
Other important metrics to assess Legend Biotech's financial health include:
- P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
- Annual: -16.81
- Quarterly: 28.30
- TTM: -17.78
- P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
- Annual: 2.86
- Quarterly: 2.86
- TTM: 3.03
- P/C Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
- Annual: -20.65
- Quarterly: -36.25
- TTM: -21.96
- PEG Ratio (Price/Earnings to Growth Ratio) - measures the company's valuation considering its earnings growth:
- Annual: 0.25
- Quarterly: 0.00
- TTM: -0.23
These metrics provide insights into Legend Biotech's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual Price/Sales Ratio
4.74
Quarterly Price/Sales Ratio
15.95
TTM Price/Sales Ratio
5.04
Legend Biotech Historical Price/Sales Ratio
Historical P/E Ratio
Historical P/B Ratio
Historical P/C Ratio
Historical PEG Ratio
Legend Biotech Historical Financial Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | Price/Sales Ratio | P/E Ratio | P/B Ratio | P/C Ratio | PEG Ratio |
|---|---|---|---|---|---|
| 2024 | 4.74 | -16.81 | 2.86 | -20.65 | 0.25 |
| 2023 | 18.58 | -10.22 | 4.23 | -13.47 | -2.21 |
| 2022 | 33.93 | -8.89 | 5.33 | -19.85 | -3.48 |
| 2021 | 36.56 | -8.50 | 6.97 | -16.54 | -1.28 |
| 2020 | 21.98 | -5.48 | 5.94 | -7.46 | -0.04 |
| 2019 | 42.65 | -18.37 | -19.88 | -29.40 | -0.01 |
| 2018 | 37.65 | -664.51 | 213.90 | 6.01 | 4.77 |
| 2017 | 103.51 | 260.77 | 200.73 | -1027.83 | 0.00 |
Related Metrics
Explore detailed financial metrics and analysis for LEGN.